- Home
- MP vs QGEN Comparison
MP vs QGEN Comparison
Compare MP & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MP | QGEN |
|---|---|---|
| Founded | 2017 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 10.2B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | MP | QGEN |
|---|---|---|
| Price | $68.63 | $54.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $70.92 | $48.84 |
| AVG Volume (30 Days) | ★ 8.3M | 2.4M |
| Earning Date | 02-19-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 4.33% |
| EPS Growth | N/A | ★ 331.25 |
| EPS | N/A | ★ 1.94 |
| Revenue | $232,742,000.00 | ★ $2,070,781,000.00 |
| Revenue This Year | $34.68 | $7.12 |
| Revenue Next Year | $137.40 | $5.95 |
| P/E Ratio | ★ N/A | $28.76 |
| Revenue Growth | ★ 26.44 | 5.32 |
| 52 Week Low | $18.64 | $39.61 |
| 52 Week High | $100.25 | $57.82 |
Technical Indicators
Market Signals| Indicator | MP | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 61.36 | 71.70 |
| Support Level | $61.52 | $46.07 |
| Resistance Level | $71.69 | $57.82 |
| Average True Range (ATR) | 4.71 | 1.99 |
| MACD | 0.95 | 0.89 |
| Stochastic Oscillator | 85.18 | 71.16 |
Price Performance
Historical ComparisonAbout MP MP Materials Corp.
MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).